HLA‐A2‐restricted glypican‐3 peptide‐specific CTL clones induced by peptide vaccine show high avidity and antigen‐specific killing activity against tumor cellsToshiaki Yoshikawa, Tetsuya Nakatsura, Shinichi Hayashi et al.|Cancer Science|2011Cited by 78
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapyDaisuke Nobuoka, Tetsuya Nakatsura, Toshiaki Yoshikawa et al.|Cancer Immunology Immunotherapy|2012Cited by 48
Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinomaKazuya Ofuji, Tetsuya Nakatsura, Keigo Saito et al.|Oncotarget|2016Cited by 28
Abstract 2688: Establishment of high avidity CTL clones induced by HLA-A2 restricted glypican-3 (GPC3) peptide vaccineToshiaki Yoshikawa, Tetsuya Nakatsura, Munehide Nakatsugawa et al.|Cancer Research|2011Cited by 0